Vote for BJP in urban local bodies" poll for "triple engine" govt in UP: Adityanath
UP: Man booked for attempting to rape 5-year-old girl
Congress to mark 100 days of Bharat Jodo Yatra with concert in Jaipur
BJYM, Hindu outfits put off planned protest march at AMU
Karachi battles gas crisis; residents face unannounced load shedding, 2-hr gas supply in a day
Elderly man in judicial custody dies during treatment in UP hospital
Himachal Pradesh skittle Haryana for 46, take 200-run lead on Day 1
Pak court grants protective bail to PM Shehbaz"s son Suleman in money laundering case
British Library celebrates India ties with exhibition on Hampi
Nine policemen suspended after suspect dies in police custody in UP
Gangster"s property attached in UP"s Pratapgarh district
Maoists torch construction company vehicles in Jharkhand’s Chatra district
Sino-India border situation "generally stable": China on Yangtse clash
Babar Azam not taking advice from seniors, claims Shahid Afridi
Qlite Global launches their exclusive Grand Experience Centre
"Disillusioned with central leadership": Sikkim BJP president says he has resigned
2001 attack anniversary: Ready to guard new Parliament if directed, say CRPF heroes
Class 2 student dies after scuffle with fellow students in UP
Three killed in accident in UP"s Lakhimpur KheriLakhimpur Kheri (UP), Dec 13 (PTI) Three motorcycle borne youths were killed and "
Abandoned girl child from Assam adopted by Spanish professor
The timeline for a novel Coronavirus vaccine is all but set. Though there is still a bit of uncertainty, most experts, and others who should know, agree that a vaccine would become a reality by early next year, if not earlier. The next point of interest in the vaccine seems to be the price at which it would be made available to the public. That question is also being slowly answered.
New Delhi: The timeline for a novel Coronavirus vaccine is all but set. Though there is still a bit of uncertainty, most experts, and others who should know, agree that a vaccine would become a reality by early next year, if not earlier. The next point of interest in the vaccine seems to be the price at which it would be made available to the public. That question is also being slowly answered.
On Friday, Serum Institute of India, the world’s largest manufacturer of vaccines by volume, said at least 100 million doses of potentially billions that it plans to produce, would be made available for as low as US$ 3 (less than Rs 240) per dose. This is at par with the lowest price indications that have been suggested till now for the different vaccine candidates currently under development. Serum said this low price would be enabled through a new US$ 150 million funding it is receiving from the Bill and Melinda Gates Foundation to ‘accelerate’ the production of Coronavirus vaccines. Serum has agreements with at least two vaccine developers, Oxford University-AstraZeneca and Novavax, to produce and supply their vaccines once they are finalised and approved.
Moderna, one of the front-runners to develop a Coronavirus vaccine, is reported to have said that it could price its vaccine between US$50 and US$60 (between Rs 3,700 and Rs 4,500) per dose. The vaccine being developed by Pfizer is expected to be priced around US$ per dose (about Rs 3,000). Serum Institute itself has earlier indicated that the Oxford University vaccine that it would manufacture could be priced at less than Rs 1,000. But these are not standard prices. The price of the vaccines would differ from country to country, and also within countries, and within different target group of recipients. For example, the US$ 39 price for Moderna vaccine is only for the United States market. It is expected to be cheaper in many other countries.
AstraZeneca, Johnson & Johnson, and Pfizer have indicated that they did not intend to profit from the vaccines, and would be willing to sell it at the cost price. However, Moderna has said it would not sell it at cost.
Your support to NYOOOZ will help us to continue create and publish news for and from smaller cities, which also need equal voice as much as citizens living in bigger cities have through mainstream media organizations.
